Logista launches flu campaign. Logista stock sits 8.21 percent below its high

Published on 10/07/2026 at 14:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Logista forecasts 6 million vaccine doses through 3,200 supply points. Logista stock costs EUR 34.66 on October 7, 2026 versus EUR 34.36.

Logista, ES0105027009, Illustration mit AI erstellt.

Logista (ISIN ES0105027009) was trading at EUR 34.66 at Lang & Schwarz on October 7, 2026 at 1:46 p.m. CEST, plus 0.87 percent versus the prior close of EUR 34.36. According to Logista on October 6, 2026, its pharmaceutical business launched an influenza vaccination campaign forecasting 6 million doses through more than 3,200 supply points.

Flu campaign expands pharma role

The campaign gives investors a concrete measure of Logista's pharmaceutical distribution reach during the current vaccination season. The company distributes pharmaceuticals alongside tobacco, convenience products, books, transport services and electronic transactions across several European markets.

Logista's official figures show 200,000 points of sale and 700 central and regional platforms. That infrastructure matters because the campaign combines a defined volume forecast with a broad distribution network rather than relying on a single customer or location.

Fiscal 2025 set the earnings base

In fiscal 2025, Logista reported economic sales of EUR 1.809 billion, adjusted EBIT of EUR 378.0 million and net profit of EUR 281.0 million, according to Logista. Adjusted EBIT therefore equaled 20.89 percent of economic sales, calculated from those two reported figures.

The same fiscal-year figures provide a useful benchmark for the newer pharmaceutical push. The company also allocated EUR 277.0 million in dividends for fiscal 2025, a payout that makes operating cash generation and future earnings progression important counterweights to the campaign's growth signal.

Stock remains below yearly high

At EUR 34.66, the Lang & Schwarz price stood 8.21 percent below the 52-week high of EUR 37.76 and 23.03 percent above the low of EUR 28.16 on October 7, 2026. Market capitalization was EUR 4.6 billion at the same market-data snapshot.

Logista is scheduled to publish its annual 2026 earnings on November 5, 2026, according to MarketScreener. The next results will show whether the pharmaceutical expansion can complement the established distribution base as investors compare current operations with fiscal 2025's EUR 378.0 million adjusted EBIT.

The further course of trading is shown by the continuously updated real-time quote of Logista stock.